Skip to content
10-Q

Quarterly Report

ULIXE CORP.

0001393905-25-000109

← back to feed
Filed
Mar 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Mar 6, 2025 139.94M sh
Operating Cash Flow Q2 2025 · Jan 31, 2025 $13.47K
Operating Cash Flow restated Q2 2025 · Jan 31, 2024 $20.25K
Cash And Equivalents Q2 2025 · Jan 31, 2025 $8
Cash And Equivalents Q2 2025 · Jul 31, 2024 $39
Stockholders Equity Q2 2025 · Jan 31, 2025 $139.66K
Stockholders Equity Q2 2025 · Jul 31, 2024 $155.9K
Current Liabilities Q2 2025 · Jan 31, 2025 $110.98K
Current Liabilities Q2 2025 · Jul 31, 2024 $81.27K
Total Liabilities Q2 2025 · Jan 31, 2025 $110.98K
Total Liabilities Q2 2025 · Jul 31, 2024 $81.27K
Current Assets Q2 2025 · Jan 31, 2025 $15.01K
Current Assets Q2 2025 · Jul 31, 2024 $15.04K
Total Assets Q2 2025 · Jan 31, 2025 $250.63K
Total Assets Q2 2025 · Jul 31, 2024 $237.16K
Eps Basic Q2 2025 · Jan 31, 2025 $0.00
Eps Basic Q2 2025 · Jan 31, 2025 $0.00
Eps Basic Q2 2025 · Jan 31, 2024 $0.00
Eps Basic Q2 2025 · Jan 31, 2024 $0.00
Sga Expense Q2 2025 · Jan 31, 2025 $4.17K
Sga Expense Q2 2025 · Jan 31, 2025 $16.24K
Sga Expense Q2 2025 · Jan 31, 2024 $4.92K
Sga Expense Q2 2025 · Jan 31, 2024 $10.16K
Net Income Q2 2025 · Jan 31, 2025 −$16.24K
Net Income Q2 2025 · Jan 31, 2024 −$10.16K